Pfizer
Executive Summary
This appears to be incomplete or erroneous data - Pfizer is a major US pharmaceutical company headquartered in New York, not a Chinese entity. Pfizer has no BIOSECURE risk as it's an American multinational corporation. If evaluating the actual Pfizer Inc., they would be a potential partner rather than acquisition target, with strong pipeline capabilities across oncology, vaccines, and rare diseases.
Structure: Data inconsistency detected - Pfizer Inc. is a US publicly traded company (NYSE: PFE) with standard Delaware corporation structure. If this refers to a different Chinese entity with similar naming, corporate structure details are not available in the provided data.
Ownership & Shareholder Structure
CStone Pharmaceuticals → Pfizer
CStone-Pfizer sugemalimab collaboration for oncology in China.
WuXi AppTec → Pfizer
WuXi AppTec provides CDMO services to Pfizer. Key API manufacturing relationship.
Asymchem Laboratories → Pfizer
Asymchem manufactured Paxlovid API for Pfizer. Key CDMO relationship.
BIOSECURE Risk
If referring to US Pfizer Inc., no BIOSECURE risk as it's an American company. If referring to a Chinese entity, insufficient data to assess risk properly.
Mitigation: Not applicable for US Pfizer Inc.
BD Intelligence
Therapeutic Areas:
Recent Deals: No data available - entity information appears incomplete or incorrect
Approach: Clarify entity identity before proceeding - data suggests confusion between US Pfizer Inc. and unknown Chinese entity
Red Flags
- ⚠Entity data inconsistency - Chinese company classification with US pharma giant name
- ⚠No key personnel data available
- ⚠No subsidiary information provided
- ⚠No recent corporate events recorded
- ⚠Missing ticker symbol despite apparent public company status
Quick Facts
- Key People
- 0
- Subsidiaries
- 0
- CDMO/CRO Subs
- 0
- Genomics Subs
- 0
- Direct BIOSECURE
- 0
- Corp Events
- 0
- Gov-Connected
- 0
- Clinical Trials
- 0
- Publications
- 0
- Drug Molecules
- 0
- Relationships
- 11
Sources & Methodology
Clinical trials data: ClinicalTrials.gov API v2 (0 trials linked to this entity)
SEC BIOSECURE filings: EDGAR EFTS full-text search (850+ filings from 230 companies)
Publications: Europe PMC API (0 publications indexed)
Drug molecules: ChEMBL database (European Bioinformatics Institute)
Financial data: East Money (东方财富) datacenter API / CNINFO (巨潮资讯网)
Corporate structure: Company official filings, HKEX/SSE/SZSE disclosures
Executive profiles: Company official biographies, SEC filings, LinkedIn (where verified)
Data is collected from public sources and updated weekly. Corporate intelligence is verified by a native Mandarin-speaking analyst against Chinese-language primary sources including Tianyancha (天眼查), GSXT (国家企业信用信息公示系统), and CNINFO (巨潮资讯网). This is not financial or legal advice.